Long-Term Safety and Efficacy of Siluron2000 with Pars Plana Vitrectomy in the Treatment of Patients with Severe Vitreoretinopathy and Chronic Macular Holes

References

• Caramoy A, Hagedorn N, Fauser S, Kugler W, Groß T, Kirchhof B. Development of emulsification-resistant silicone oils: can we go beyond 2000 mPas silicone oil? Invest Ophthalmol Vis Sci. 2011;52(8):5432–5436. doi:10.1167/iovs.11-7250
   Web of Science ®Google Scholar
• Williams RL, Day MJ, Garvey MJ, et al. Injectability of silicone oil-based tamponade agents. Br J Ophthalmol. 2011;95(2):273–276. doi:10.1136/bjo.2010.192344
   Web of Science ®Google Scholar
• Miller JB, Papakostas TD, Vavvas DG. Complications of emulsified silicone oil after retinal detachment repair. Semin Ophthalmol. 2014;29(5–6):312–318. doi:10.3109/08820538.2014.962181
   PubMed Web of Science ®Google Scholar
• Caramoy A, Fauser S, Kirchhof B. Early emulsification of silicone oil (2000 cs) in minimally invasive transconjunctival vitreoretinal surgery”. Klin Monatsbl Augenheilkd. 2010;228:477–479.
   Web of Science ®Google Scholar
• Mandelcorn E, Howarth D, Mandelcorn M. Silicone oil-induced bilateral granulomatous uveitis. Can J Ophthalmol. 2010;45(3):288–289. doi:10.3129/i09-235
   Web of Science ®Google Scholar
• Barca F, Caporossi T, Rizzo S. Silicone oil: different physical properties and clinical applications. Biomed Res Int. 2014;2014(502143):1–7. doi:10.1155/2014/502143
   Web of Science ®Google Scholar
• Stalmans P, Pinxten AM, Wong DS. Cohort safety and efficacy study of Siluron2000 emulsification-resistant silicone oil and F4H5 in the treatment of full-thickness macular hole. Retina. 2015;35(12):2558–2566. doi:10.1097/IAE.0000000000000647
   Web of Science ®Google Scholar
• Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236–1240. doi:10.1167/iovs.05-0981
   PubMed Web of Science ®Google Scholar
• Shen Y-D, Yang C-M. Extended silicone oil tamponade in primary vitrectomy for complex retinal detachment in proliferative diabetic retinopathy: a long-term follow-up study. Eur J Ophthalmol. 2007;17(6):954–960. doi:10.1177/112067210701700614
   PubMed Web of Science ®Google Scholar
• Cibis PA, Becker B, Okun E, Canaan S. The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol. 1962;68(5):590–599. doi:10.1001/archopht.1962.00960030594005
   PubMedGoogle Scholar
• Zivojnović R, Mertens DA, Peperkamp E. Liquid silicone in amotio surgery (II). Report on 280 cases-further development of the technic. Klin Monbl Augenheilkd. 1982;181(6):444–452.
   Web of Science ®Google Scholar
• Altan T, Acar N, Kapran Z. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment. Retina. 2008;28(9):1201–1206. doi:10.1097/IAE.0b013e3181853d3c
   Web of Science ®Google Scholar
• Schurmans A, van Calster J, Stalmans P. Macular hole surgery with Inner limiting membrane peeling, endodrainage, and heavy silicone oil tamponade. Am J Ophthalmol. 2009;147(3):495–500. doi:10.1016/j.ajo.2008.09.003
   Web of Science ®Google Scholar
• Ichhpujani P, Jindal A, Jay Katz L. Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol. 2009;247(12):1585–1593. doi:10.1007/s00417-009-1155-x
   PubMed Web of Science ®Google Scholar
• Matić S, Suić SP, Biuk D. Influence of silicone oil tamponade after vitrectomy on intraocular pressure. Coll Antropol. 2013;37:227–235.
   PubMedGoogle Scholar
• Heidenkummer HP, Messmer EM, Kampik A. Recurrent vitreoretinal membranes in intravitreal silicone oil tamponade. Morphologic and immunohistochemical studies. Ophthalmologe. 1996;93:121–125.
   Google Scholar
• Kociok N, Gavranic C, Kirchhof B, Joussen AM. Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane. Graefes Arch Clin Exp Ophthalmol. 2005;243(4):345–358. doi:10.1007/s00417-004-1039-z
   Web of Science ®Google Scholar
• Zhao X-J, Tang -N-N, Lian Y, Liu B-Q, Li Y-H, Lu L. Analysis of the rates of emulsification in intraocular silicone oil tamponades of differing viscosities. Int J Ophthalmol. 2020;13(5):761. doi:10.18240/ijo.2020.05.10
   Web of Science ®Google Scholar
• Duan A, She H, Qi Y. Complications after heavy silicone oil tamponade in complicated retinal detachment. Retina. 2011;31(3):547–552. doi:10.1097/IAE.0b013e3181eef2fd
   PubMed Web of Science ®Google Scholar
• Prazeres J, Magalhães O, Lucatto LFA, et al. Heavy silicone oil as a long-term endotamponade agent for complicated retinal detachments. Biomed Res Int. 2014;2014. doi:10.1155/2014/136031
   Web of Science ®Google Scholar
• Zafar S, Shakir M, Mahmood SA, et al. Injectability of silicone oil-based tamponade agents. Br J Ophthalmol. 2011;52:5432–5436. doi:10.1097/00006982-200104000-00002
   Web of Science ®Google Scholar
• Scott IU, Flynn HW Jr, Murray TG, Smiddy WE, Davis JL, Feuer WJ. Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. Arch Ophthalmol. 2005;123(4):473–478. doi:10.1001/archopht.123.4.473
   PubMedGoogle Scholar
• Morphis G, Irigoyen C, Eleuteri A, Stappler T, Pearce I, Heimann H. Retrospective review of 50 eyes with long-term silicone oil tamponade for more than 12 months. Graefes Arch Clin Exp Ophthalmol. 2012;250(5):645–652. doi:10.1007/s00417-011-1873-8
   Web of Science ®Google Scholar
• Lam RF, Cheung BTO, Yuen CYF, Wong D, Lam DSC, Lai WW. Retinal redetachment after silicone oil removal in proliferative vitreoretinopathy: a prognostic factor analysis. Am J Ophthalmol. 2008;145(3):527–533. doi:10.1016/j.ajo.2007.10.015
   PubMed Web of Science ®Google Scholar
• Herbrig E, Sandner D, Engelmann K. Anatomical and functional results of endotamponade with heavy silicone oil – Densiron® 68 – in complicated retinal detachment. Ophthalmic Res. 2007;39(4):198–206. doi:10.1159/000104681
   Web of Science ®Google Scholar
• Wong D, Meurs JCV, Stappler T, et al. A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol. 2005;89(6):662–665. doi:10.1136/bjo.2004.055178
   PubMed Web of Science ®Google Scholar
• Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, di Bartolo E, Belting C. A new heavy silicone oil (HWS 46-3000) used as a prolonged internal tamponade agent in complicated vitreoretinal surgery: a pilot study. Retina. 2007;27(5):613–620. doi:10.1097/01.iae.0000251228.33870.64
   PubMed Web of Science ®Google Scholar
• Rizzo S, Genovesi-Ebert F, Belting C, Vento A, Cresti F. A pilot study on the use of silicone oil–RMN3 as heavier-than-water endotamponade agent. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1153–1157. doi:10.1007/s00417-005-0015-6
   Web of Science ®Google Scholar
• Kirchhof B, Wong D, van Meurs J, Hilgers RD, Macek M. Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol. 2002;133(1):95–101. doi:10.1016/S0002-9394(01)01295-8
   PubMed Web of Science ®Google Scholar
• Kornmann HL, Gedde SJ. Glaucoma management after vitreoretinal surgeries. Curr Opin Ophthalmol. 2016;27(2):125. doi:10.1097/ICU.0000000000000238
   Web of Science ®Google Scholar
• Roberti G, Oddone F, Agnifili L, et al. Steroid-induced glaucoma: epidemiology, pathophysiology, and clinical management. Surv Ophthalmol. 2020;65(4):458–472. doi:10.1016/J.SURVOPHTHAL.2020.01.002
   PubMed Web of Science ®Google Scholar
• Sandner D, Engelmann K. First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol. 2006;244(5):609–619. doi:10.1007/s00417-005-0110-8
   PubMed Web of Science ®Google Scholar
• Sandner D, Herbrig E, Engelmann K. High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol. 2007;245(8):1097–1105. doi:10.1007/s00417-006-0496-y
   PubMed Web of Science ®Google Scholar
• Wickham L, Tranos P, Hiscott P, Charteris D. The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol. 2010;248(9):1225–1231. doi:10.1007/s00417-010-1358-1
   Web of Science ®Google Scholar
• Majid MA, Hussin HM, Biswas S, Haynes RJ, Mayer EJ, Dick AD. Emulsification of Densiron-68 used in inferior retinal detachment surgery. Eye. 2008;22(1):152–157.
   Web of Science ®Google Scholar
• Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Experiment Ophthalmol. 2003;31(5):408–414. doi:10.1046/j.1442-9071.2003.00687.x
   Web of Science ®Google Scholar
• Bottoni F, Sborgia M, Arpa P, et al. Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1993;231(11):619–628. doi:10.1007/BF00921955
   PubMed Web of Science ®Google Scholar